Professor Rayaz Malik
, BSc. (Hons), MSc., MB ChB, PhD, FRCP.
Rayaz Malik graduated in Medicine from the University of Aberdeen in 1991, obtained his MRCP (London) in 1996, PhD from the University of Manchester in 1997 and was elected to become a fellow of the Royal College of Physicians in 2007. He was appointed as Consultant Physician and Senior Lecturer in 2001. In 2008 he became Professor of Medicine and Consultant Physician in the Central Manchester University Teaching Hospitals and the University of Manchester. In 2014 he was appointed as Professor of Medicine at Weill Cornell Medicine and remains an honorary Professor of Medicine at the University of Manchester and visiting Professor of Medicine at Manchester Metropolitan University. He was appointed as the Organizational Official in November 2016 and as the Assistant Dean for Clinical Research at Weill Cornell Medicine-Qatar in February 2019.
His research focuses on the pathogenesis, assessment and treatment of diabetic and other peripheral neuropathies and central neurodegenerative disorders. Over ~20 years he has pioneered the use of corneal confocal microscopy, a non-invasive ophthalmic instrument, to quantify neurodegeneration in diabetic and other peripheral neuropathies and more recently in patients with Multiple Sclerosis, Parkinson’s disease, Stroke, Dementia, Autism and long-COVID. He has a track record of successfully completing large clinical research studies, having completed 5 longitudinal projects as a Principal Investigator in the UK funded by the NIH ($4,485,655), JDRFI ($4,800,000) and EUFP7 ($4,800,000). He is currently the Lead PI for a study on CCM in Multiple sclerosis in Qatar, funded by ECTRIMS ($152,100), in Manchester on Parkinson’s disease funded by MJFF ($299,882) and on studies funded by Qatar Foundation to use AI to identify hypoglycemia from ECG’s ($650,000) and corneal confocal microscopy in dementia ($680,000).
Based on an independent analysis of his published research over the last 10 years compiled by Expertscape, the world’s leading index of academic achievement and expertise in healthcare, he was ranked the 2nd most influential researcher in the UK on diabetes complications in 2019. He has published 401 peer reviewed papers and has a Web of Science h-index=55; Google Scholar h-index=89; i10-index=337.
He was the President of Neurodiab (the diabetic neuropathy study group of the EASD) from 2009-2012 and recipient of the prestigious 2019 Camillo Golgi Award from the European Association for the Study of Diabetes. He is associate editor for J of Diabetes Complications (2012-present), PLOS One (2016-present), BMC Neurology (2009-present) and Scientific Reports (2019-present).
